Statizoid

Health in Italy

1,136 indicators covering health for Italy.

IndicatorLatest Year10-yr change Rank
Maternal mortality ratio vs mean daily income 4.59 2020 down 31.8% 168th
Hib (Hib3) immunization coverage among 1-year-olds (%) 94.0% 2025 up 1.1% 70th
Diphtheria tetanus toxoid and pertussis third-dose  (DTP3) 95.0% 2025 up 2.2% 59th
Measles-containing-vaccine first-dose (MCV1) immunization coverage 95.0% 2025 up 11.8% 51st
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) 95.0% 2025 up 2.2% 58th
Measles-containing-vaccine second-dose (MCV2) immunization coverage 83.0% 2025 unchanged 98th
Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 95.0% 2025 unchanged 90th
Implementation of tools to monitor economic and environmental tourism 2 2022 unchanged 62nd
New HIV infections 0.1 2025 unchanged 70th
Mean HDL cholesterol, age-standardized 1.4 2018 unchanged 16th
Mean total cholesterol, crude 5.1 2018 down 3.8% 11th
Mean Non-HDL cholesterol, age-standardized 3.5 2018 down 7.9% 51st
Mean HDL cholesterol, crude 1.4 2018 unchanged 18th
Mean Non-HDL cholesterol, crude 3.7 2018 down 5.1% 18th
Mean total cholesterol, age-standardized 4.9 2018 down 5.8% 25th
Infant mortality rates by NUTS 2 region 2.5 2024 down 10.7% 27th
Prevalence of anemia among children 14.9% 2019 up 22.1% 165th
Life expectancy by age, sex and NUTS 2 region 83.7 2024 up 1.1% 5th
Births attended by skilled health staff 99.8% 2020 down 0.1% 30th
Births attended by health staff sdgs 99.8 2020 down 0.1% 30th
Number of deaths among children ages 10 to 14 years 198 2021 down 30.5% 101st
Adolescent mortality rate 0.352 2021 down 30.4% 189th
Adults (ages 15+) living with HIV 150,000 2024 up 25.0% 31st
Prevalence of current tobacco use 22.4% 2024 down 5.5% 64th
Prevalence of current tobacco use, females 19.3% 2024 up 0.5% 35th
Prevalence of current tobacco use, males 25.6% 2024 down 9.2% 90th
Physicians 4.19 per 1,000 people 2022 up 10.0% 26th
Physicians per 1000 people 4.19 2022 up 10.0% 26th
Share of the population infected with hiv 0.2508 2024 down 7.4% 92nd
Global vaccination coverage 94 2024 down 1.1% 61st
Proportion of population with primary reliance on clean fuels and 99.0% 2024 up 1.0% 29th
Under-five mortality rate, by sex 2.7 per 1,000 live births 2024 down 24.9% 165th
Infant mortality rate 2.29 per 1,000 live births 2024 down 25.0% 165th
Neonatal mortality rate 1.8 per 1,000 live births 2024 down 17.7% 159th
Infant mortality by NUTS 2 region 932 2024 down 34.8% 6th
Number of incident tuberculosis cases 3,000 2024 down 26.8% 105th
Incidence of tuberculosis 5 2024 down 25.4% 164th
Number of incident tuberculosis cases 150 2024 down 28.6% 93rd
Number of deaths due to tuberculosis, excluding HIV 300 2024 up 3.4% 95th
Deaths due to tuberculosis among HIV-negative people 0.51 2024 up 6.2% 138th
Tuberculosis deaths by hiv status 30 2024 down 31.8% 95th
Tuberculosis case fatality rate 11 2024 up 37.5% 93rd
Life satisfaction vs child mortality 6.57 2025 up 10.0% 37th
Incidence of tuberculosis sdgs 5 2024 down 25.4% 173rd
Tuberculosis deaths region 330 2024 down 2.9% 99th
Tuberculosis death rate 0.56 2024 up 1.8% 154th
Tuberculosis deaths who 330 2024 down 2.9% 99th
People using safely managed sanitation services, rural 77.3% 2024 down 0.6% 20th
Tuberculosis incidence 5 per 100,000 people 2024 down 25.4% 159th
Tuberculosis patients with hiv share 5.2 2024 up 4.0% 78th
Life expectancy prados de la escosura 82.4 2020 up 0.3% 13th
Prevalence of hiv percentage of males and females ages 15 24 infected 0.1 2024 unchanged 70th
Tuberculosis - new and relapse cases 2,987 2024 down 1.1% 95th
Adults (ages 15+) and children (ages 0-14) newly infected with HIV 4,000 2024 down 9.1% 39th
Tuberculosis treatment coverage 100 2024 up 23.5% 4th
AIDS estimated deaths 500 UNAIDS estimates 2024 unchanged 64th
Mean BMI (kg/m²) 25.6 2016 unchanged 110th
Rubella - number of reported cases 1 2025 down 93.8% 76th
Treatment success rate: new TB cases 95 2003 up 18.8% 13th
Yellow fever - number of reported cases 0 2025 — 26th